Browse > Article
http://dx.doi.org/10.4333/KPS.2007.37.3.173

Effect of Ethanolamine Salts and Enhancers on the Percutaneous Absorption of Meloxicam from a Pressure Sensitive Adhesive Matrix  

Ki, Han-Moe (BK21 Project Team, College of Pharmacy, Chosun University)
Cheong, Hyun-Ah (BK21 Project Team, College of Pharmacy, Chosun University)
Choi, Hoo-Kyun (BK21 Project Team, College of Pharmacy, Chosun University)
Publication Information
Journal of Pharmaceutical Investigation / v.37, no.3, 2007 , pp. 173-177 More about this Journal
Abstract
The purpose of this study was to investigate the effect of salt formation on the percutaneous absorption of meloxicam through hairless mouse skin from a pressure sensitive adhesive (PSA) matrix. In addition, the influences of enhancers on the permeation of meloxicam or meloxicam-ethanolamine (MX-EA) salts across the hairless mouse skin were evaluated using a flow-through diffusion cell system. The salt formation of meloxicam resulted in lower permeation rate than the parent drug. $Span^{(R)}$ 80 provided the highest enhancing effect for meloxicam and meloxicam monoethanolamine salt. The maximum amount of the drug that can be loaded without retarding permeation rate was different depending on the compound. No relationship was found between the fluxes of meloxicam or MX-EA salts from saturated solutions and those from PSA matrices containing the same enhancer.
Keywords
Salt; Meloxicam; PSA matrix; Enhancer; Skin permeability;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 E. Furst Daniel, Meloxicam: Selective COX-2 Inhibition in Clinical Practice, Semin. Arthritis. Rheum., 26, 6, SUPPL 1, 21-27 (1997)   DOI   ScienceOn
2 G. C. Mazzenga, B. Berner, The transdermal delivery of zwitterionic drugs I: the solubility of zwitterion salts, J. Control. Release, 16, 77-88 (1991)   DOI   ScienceOn
3 B. Thomas, and B. Finnin, The transdermal revolution, Drug Discov. Today, 16, 697-703 (2004)
4 M. Buffum and J. C. Buffum, Nonsteroidal anti-inflammtory drugs in the elderly, Pain. Manag. Nurs., 1, 2, 40-50 (2000)   DOI   ScienceOn
5 C. S. Asbill and B. B. Michniak, Percutaneous penetration enhancers: local versus transdermal activity, Pharmaceut. Sci. Tech. Today, 3, 1, 36-41 (2000)   DOI   ScienceOn
6 S. C. McNeill, R. O. Potts and M. L. Francoeur, Local enhanced topical delivery (LETD) of drugs: does it truly exist?, Pharm. Res., 9, 1442-1427 (1992)   DOI
7 D. Turck, U. Busch, G. Heinzel and H. Narjes, Clinical pharmacokinetics of meloxicam, Arzneimittelforsch, 47, 3, 253-258 (1997)
8 Y. J. Cho and H. K. Choi, Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix, Int. J. Pharm., 169, 95-104 (1998)   DOI   ScienceOn
9 H. M. Ki and H. K. Choi, The effect of meloxicam/ethanolamine salt formation on percutaneus absorption of meloxicam, Arch. Pharm. Res., 30, 2, 215-221 (2007)   과학기술학회마을   DOI   ScienceOn
10 H. A. Cheong, H. K. Choi, Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix, Eur. J. Pharm. Sci., 18, 149-153 (2003)   DOI   ScienceOn
11 T. Kokubo, K. Sugibayashi and Y. Morimoto, Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems, Pharm. Res., 11, 104-107 (1994)   DOI
12 A. Femenial-Font, C. Balaguer-Fernandez, Merno V., Rodilla V., Lopez-Casellano A., Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate, Eur. J. Pharm. Biopharm., 61, 50-55 (2005)   DOI   ScienceOn